Search - tctmd.com

Displaying 21 - 40 of 59

Sort: Relevancy | Date

News Daily News

Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early

Todd Neale

October 09, 2017

News Industry News

Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death

October 02, 2017

News Daily News

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Caitlin E. Cox

September 29, 2017

News Daily News

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Michael O'Riordan

September 27, 2017

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Shelley Wood

September 25, 2017

Podcast TCTMD Talking Points

Episode 30: PARTNER 2 Quality of Life

September 20, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Opinion Fellow Talk

Physical Fitness for Fellows: Better Late Than Never

Bhuvnesh Aggarwal, MD

August 18, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

News Daily News

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

Michael O'Riordan

July 17, 2017

News Daily News

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

L.A. McKeown

July 14, 2017

News Industry News

Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors

July 12, 2017

News Conference News SCCT 2017

Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration

Yael L. Maxwell

July 09, 2017

News Daily News

Incidental Findings on CT Angiography Predict All-Cause Mortality Following TAVR

Alison Palkhivala

July 07, 2017

News Daily News

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Michael O'Riordan

June 26, 2017

News Conference News TVT 2017

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Michael O'Riordan

June 20, 2017

News Conference News TVT 2017

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Michael O'Riordan

June 17, 2017

News Conference News TVT 2017

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

Shelley Wood

June 16, 2017

Presentation TVT 2017

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

Presenter: David J. Cohen, Jeffrey J. Popma, Vinod H. Thourani

June 16, 2017

News Industry News

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

June 16, 2017

Advertisement

Rivaroxaban Trial in Patients With Embolic Stroke of Undetermined Source Stopped Early

Geisinger and Boehringer Ingelheim collaborate to create a predictive model to help improve health outcomes for people with type 2 diabetes at greatest risk of serious long-term complications, including cardiovascular death

Hemodynamics of First-Gen Sapien Valve Hold Up Well Over the Years: PARTNER Analysis

Paravalvular Regurgitation With Sapien 3 Rare but Still Can Be Deadly

Valve Deterioration and Durability Definitions Now Standardized in New Guide

Episode 30: PARTNER 2 Quality of Life

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

Physical Fitness for Fellows: Better Late Than Never

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows

Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing

Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors

Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration

Incidental Findings on CT Angiography Predict All-Cause Mortality Following TAVR

TAVR Use Triples in France, With Docs Treating Lower-Risk Patients

Merits of Minimalist TAVR: Patient Satisfaction and a Better Bottom Line

Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base

Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content